An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors

Clinical trial NCT02616211 · COMPLETED

Trial details

NCT number: NCT02616211
Sponsor: Mayo Clinic
Status: COMPLETED
Study type: OBSERVATIONAL

Adenocarcinoma of Lung Lung Neoplasm Cancer of Lung Lung Cancer Pulmonary Cancer EGFR Genes ALK Genes

Start date: 2014-10-01
Primary completion: 2018-10-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.